Provided by Tiger Trade Technology Pte. Ltd.

SILO PHARMA INC.

1.49
-0.0200-1.32%
Volume:10.32K
Turnover:15.43K
Market Cap:2.61M
PE:-0.29
High:1.52
Open:1.51
Low:1.48
Close:1.51
52wk High:10.87
52wk Low:1.46
Shares:1.75M
Float Shares:1.52M
Volume Ratio:0.78
T/O Rate:0.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0667
EPS(LYR):-7.5654
ROE:-91.23%
ROA:-44.25%
PB:0.53
PE(LYR):-0.20

Loading ...

Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 18, 2022

Major Issues Report

8-K - Current report
Sep 30, 2022

Major Issues Report

8-K - Current report
Sep 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 20, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 15, 2022

Major Issues Report

8-K - Current report
Sep 09, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 29, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Aug 01, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 25, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2022

Major Issues Report

8-K - Current report
Mar 07, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Major Issues Report

8-K - Current report
Dec 07, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2021

Major Issues Report

8-K - Current report
Sep 27, 2021

Major Issues Report

8-K - Current report